MII IG Kerndatensatz-Modul Onkologie
2027.0.0-ballot.1 -
Germany
This page is part of the MII IG Kerndatensatz-Modul Onkologie (v2027.0.0-ballot.1: Release) based on FHIR (HL7® FHIR® Standard) R4. This is the current published version in its permanent home (it will always be available at this URL). For a full list of available versions, see the Directory of published versions
This page explains the module's TNM model along one continuous course of treatment: a breast carcinoma from initial diagnosis through neoadjuvant chemotherapy and surgery to recurrence. Every station links to its example instances — same patient, same disease, five classifications.
The model in one sentence: a panel
(TNM classification)
bundles one T, N and M category observation each via hasMember; prefixes
that change interpretation (y, r, a) sit as modifierExtension on the
category; the method-of-determination prefix (c, p, u) sits as a regular
extension on Observation.code.
Clinical classification from imaging and examination. All three categories
carry the c prefix via the extension mii-ex-onko-tnm-cp-praefix — it
documents how the finding was determined, without changing what the value
means.
The biopsy reveals chest wall infiltration: the T upgrade to cT4. It remains a clinical category — pathological classification (p) requires resection, not biopsy. The panel keeps referencing the unchanged cN1/cM0: categories are reused, not duplicated.
Here the y prefix as modifierExtension
(mii-ex-onko-tnm-y-praefix)
enters: classification during/after multimodal therapy. ycT2 does not
describe the same situation as cT2 — the tumour was shrunk therapeutically.
That is precisely why it is a modifierExtension: systems that do not evaluate
it must not silently interpret the value.
Resection enables the pathological classification: p prefix in the cp
extension, y prefix still as modifierExtension — ypT0 means: no residual
tumour demonstrable in the resection specimen, after neoadjuvant therapy.
The accompanying classifications join in: lymphatic invasion
L0,
venous invasion
V0,
perineural invasion
Pn0 and the
residual status R0.
Two years later, a local recurrence with distant metastasis. The r prefix as
modifierExtension
(mii-ex-onko-tnm-r-praefix)
marks the recurrence classification; the categories themselves are clinical
(c) again.
Three follow-up instances
(after chemotherapy,
after surgery,
recurrence)
link the stations into the disease history via hasMember — oBDS chapter 17
in FHIR.
code, the latter a modifierExtension on the category — the rationale is
on the Migration from v2026 page, entry 1.ypT0 carries p in the cp extension and y as
modifierExtension at the same time (station 4).